明治薬科大学 · 未分類

研究关键词hematologic pharmacotherapy・multiple myeloma・lenalidomide skin rash・venetoclax drug interactions・gilteritinib pharmacokinetics・pneumocystis pneumonia・COVID-19 vaccination response・therapeutic drug monitoring

以下为公开数据预览。个性化匹配理由、联系角度和保存能力需要登录后使用。

• Increased trough concentration of venetoclax when combined with itraconazole for acute myeloid leukemia.2024 · Ann Hematol. 2024 Nov;103(11):4497-4502.
• Prevention of pneumocystis pneumonia in patients with hematological diseases: Efficacy of low-dose atovaquone.2023 · Int J Clin Pharmacol Ther. 2023 Nov;61(11):515-519.
• Preceding bortezomib administration for a certain period reduces the risk of lenalidomide-induced skin rash.2022 · J Clin Pharm Ther. 2022 Apr;47(4):477-482.
• 腎機能低下患者へのボルテゾミブ投与時の帯状疱疹予防におけるアシクロビル隔日投与の有効性の検討

• 官方个人主页